Analysis of clinical and molecular genetic characteristics of Wiskott-Aldrich syndrome and X-linked thrombocytopenia

Authors

  • Doina TURCAN Laboratory of Human Molecular Genetics, Institute of Mother and Child, Republic of Moldova
  • Lucia ANDRIES Laboratory of Clinical Allergology and Immunology, Nicolae Testemitanu State University of Medicine and Pharmacy, Republic of Moldova
  • Alexandr DORIF Laboratory of Human Molecular Genetics, Institute of Mother and Child; Laboratory of Clinical Allergology and Immunology, Nicolae Testemitanu State University of Medicine and Pharmacy, Republic of Moldova
  • Victoria SACARA Laboratory of Human Molecular Genetics, Institute of Mother and Child; Laboratory of Clinical Allergology and Immunology, Nicolae Testemitanu State University of Medicine and Pharmacy, Republic of Moldova

Keywords:

Wiskott Aldrich syndrome,, Xlinked thrombocytopenia,, immunodeficiency.

Abstract

Introduction. Wiskott-Aldrich syndrome is a rare X-linked disorder characterized by microthrombocytopenia, eczema, and recurrent infections. It is caused by mutations of the WAS gene which encodes the WAS protein (WASp) – a key regulator of actin polymerization in hematopoietic cells. Mutations within the WASp gene result in a wide heterogeneity of clinical disease, ranging from ‘classical WAS’ to mild asymptomatic thrombocytopenia (X-linked thrombocytopenia [XLT]), or congenital neutropenia (X-lined neutropenia [XLN]).
Case presentation. This present paper reports a phenotypical and laboratory description of two children diagnosed with WAS and one child diagnosed with XLT. The first case was a six months old male with septicemia, thrombocytopenia, eczema and petechial rash. The second case was a 2 years old boy presenting with complaints of recurrent infections, eczema and thrombocytopenia with small platelet size. The third case was a 16 years old boy who presented with thrombocytopenia and recurrent sinopulmonary infections.
Conclusions. Due to a wide spectrum of clinical findings, the diagnosis of WAS/XLT should be considered in any male patient presenting with petechiae, bruises, and congenital or early-onset thrombocytopenia associated with small platelet size.

Downloads

Download data is not yet available.

Downloads

Published

2021-06-17

Issue

Section

Case presentation

How to Cite

“Analysis of clinical and molecular genetic characteristics of Wiskott-Aldrich syndrome and X-linked thrombocytopenia” (2021) One Health & Risk Management, 2(3), pp. 61–66. Available at: https://www.ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/141 (Accessed: 10 July 2026).